Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.28%121.46B | 0.14%27.71B | -5.54%115.36B | -15.26%38.87B | 0.76%27.67B | 4.72%122.13B | 1.21%25.25B | 0.62%23.55B | 6.90%45.87B | 8.29%27.46B |
| Cost of revenue | 3.09%92.72B | -0.18%21.27B | -6.45%89.94B | -19.59%27.89B | 2.10%21.31B | 6.78%96.14B | 0.61%20.74B | 5.37%19.84B | 11.05%34.69B | 7.82%20.87B |
| Gross profit | 13.06%28.74B | 1.20%6.43B | -2.17%25.42B | -1.82%10.98B | -3.49%6.36B | -2.24%25.98B | 4.04%4.51B | -18.91%3.71B | -4.23%11.18B | 9.82%6.59B |
| Operating expense | 12.91%20.73B | 14.66%4.95B | 6.15%18.36B | 3.86%4.41B | 2.18%4.32B | -0.69%17.3B | -6.62%4.2B | 1.34%4.62B | 1.24%4.25B | 1.56%4.23B |
| Operating profit | 13.45%8.01B | -27.34%1.48B | -18.74%7.06B | -5.31%6.57B | -13.65%2.04B | -5.19%8.69B | 276.61%302M | -4,213.64%-905M | -7.30%6.93B | 28.56%2.36B |
| Net non-operating interest income (expenses) | 500.00%12M | -100.00%-2M | 85.71%-3M | 83.33%-1M | 85.71%-1M | 19.23%-21M | 62.50%-3M | 37.50%-5M | -50.00%-6M | -16.67%-7M |
| Non-operating interest income | 109.09%23M | --0 | 450.00%11M | --7M | --3M | -75.00%2M | --2M | --0 | --0 | --0 |
| Non-operating interest expense | -21.43%11M | -50.00%2M | -39.13%14M | 33.33%8M | -42.86%4M | -32.35%23M | -37.50%5M | -37.50%5M | -33.33%6M | -22.22%7M |
| Net investment income | -1.79%219M | 11.29%69M | 3.24%223M | -30.77%9M | 16.98%62M | 27.81%216M | 33.33%4M | 35.19%146M | 8.33%13M | 15.22%53M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 1,379.41%1.51B | 106.06%2M | 292.31%102M | -5M | -33M | -98.50%26M | -77.59%26M | 0 | 0 | 0 |
| Income from associates and other participating interests | 115.19%1.33B | 12.18%350M | -28.69%619M | -10.95%179M | 31.09%312M | -29.94%868M | -87.47%50M | 70.72%379M | -25.83%201M | -31.41%238M |
| Special income (charges) | -256.84%-1.02B | -200.00%-33M | 10.09%-285M | -350.00%-45M | 81.36%-11M | -138.35%-317M | -138.38%-236M | -33.33%-12M | 52.38%-10M | -1,375.00%-59M |
| Less:Other special charges | 420.00%390M | -72.73%3M | -5.06%75M | 325.00%17M | 83.33%11M | 61.22%79M | 280.00%57M | 33.33%12M | -80.95%4M | 50.00%6M |
| Less:Write off | 198.57%627M | --30M | -11.76%210M | 366.67%28M | --0 | 183.33%238M | 113.10%179M | --0 | --6M | --53M |
| Other non-operating income (expenses) | -33.96%175M | 45.16%45M | 64.60%265M | 835.29%159M | -11.43%31M | 794.44%161M | 146.59%41M | -8.11%68M | 54.55%17M | 66.67%35M |
| Income before tax | 28.32%10.24B | -20.13%1.91B | -17.04%7.98B | -4.04%6.86B | -8.52%2.39B | -20.89%9.62B | 21.05%184M | -151.48%-330M | -7.36%7.15B | -28.30%2.62B |
| Income tax | 24.59%3.02B | -26.33%761M | -2.50%2.42B | -0.44%1.59B | -8.58%1.03B | -30.05%2.48B | -343.04%-384M | -69.08%141M | -5.79%1.6B | -8.94%1.13B |
| Net income | 29.92%7.23B | -15.43%1.15B | -22.09%5.56B | -5.08%5.27B | -8.41%1.36B | -17.11%7.14B | 9,566.67%568M | -355.43%-470M | -7.82%5.55B | -38.29%1.49B |
| Net income continuous operations | 29.94%7.23B | -15.43%1.15B | -22.09%5.56B | -5.08%5.27B | -8.47%1.36B | -17.12%7.14B | 9,566.67%568M | -354.59%-471M | -7.80%5.55B | -38.27%1.49B |
| Noncontrolling interests | 50.63%839M | -12.64%159M | -34.47%557M | -15.60%238M | -19.11%182M | -5.97%850M | 100.00%214M | -15.13%129M | 6.82%282M | -40.94%225M |
| Net income attributable to the company | 27.64%6.39B | -15.87%991M | -20.42%5B | -4.51%5.03B | -6.58%1.18B | -18.42%6.29B | 415.18%353M | -2,032.26%-599M | -8.50%5.27B | -37.76%1.26B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 27.64%6.39B | -15.87%991M | -20.42%5B | -4.51%5.03B | -6.58%1.18B | -18.42%6.29B | 415.18%353M | -2,032.26%-599M | -8.50%5.27B | -37.76%1.26B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 28.16%405.55 | -15.00%63.01 | -19.33%316.44 | -2.99%317.04 | -4.47%74.13 | -17.36%392.27 | 427.92%23.02 | -2,217.47%-35.15 | -7.95%326.8 | -37.92%77.6 |
| Diluted earnings per share | 28.16%405.55 | -15.00%63.01 | -19.33%316.44 | -2.99%317.04 | -4.47%74.13 | -17.36%392.27 | 416.21%22.1978 | -2,373.66%-37.7428 | -7.95%326.8 | -37.92%77.6 |
| Dividend per share | 3.13%165 | 0 | 6.67%160 | 6.67%80 | 0 | 7.14%150 | -6.25%75 | 0 | 25.00%75 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |